HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 155 filers reported holding HEALTH CATALYST INC in Q2 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $165,233 | -93.6% | 25,858 | -90.8% | 0.00% | -100.0% |
| Q4 2023 | $2,592,596 | -48.8% | 279,978 | -44.0% | 0.01% | -50.0% |
| Q3 2023 | $5,060,121 | -3.2% | 500,012 | +19.6% | 0.01% | -9.1% |
| Q2 2023 | $5,224,851 | -57.4% | 417,988 | -60.3% | 0.01% | -64.5% |
| Q1 2023 | $12,276,443 | -30.3% | 1,051,966 | -36.5% | 0.03% | -35.4% |
| Q4 2022 | $17,602,706 | +59.2% | 1,655,946 | +45.3% | 0.05% | +41.2% |
| Q3 2022 | $11,054,000 | -19.7% | 1,139,579 | +20.0% | 0.03% | -24.4% |
| Q2 2022 | $13,764,000 | +131.6% | 949,925 | +533.3% | 0.04% | +125.0% |
| Q4 2021 | $5,943,000 | +1253.8% | 150,005 | +1151.9% | 0.02% | +566.7% |
| Q3 2020 | $439,000 | -32.7% | 11,982 | -41.9% | 0.00% | -25.0% |
| Q3 2019 | $652,000 | – | 20,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 2,247,053 | $14,358,669 | 6.41% |
| First Light Asset Management, LLC | 3,956,089 | $25,279,409 | 2.22% |
| Nepsis Inc. | 1,253,080 | $8,007,181 | 2.16% |
| Granahan Investment Management | 1,042,733 | $6,663,064 | 0.27% |
| Invenomic Capital Management LP | 850,581 | $5,435,213 | 0.26% |
| PIER 88 INVESTMENT PARTNERS LLC | 130,240 | $832,234 | 0.19% |
| ClariVest Asset Management LLC | 285,627 | $1,825,156 | 0.19% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,274,844 | $8,146,253 | 0.17% |
| CVS HEALTH Corp | 32,273 | $206,221 | 0.10% |
| Olympiad Research LP | 18,987 | $121,327 | 0.09% |